SCHEMBL6316946

SCHEMBL6316946

Cc1[nH]c2ccc(CCOS(C)(=O)=O)cc2c1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
TBXAS1 P24557 1/20 0.41
PTPN5 P54829 1/20 0.40
ALDH1A1 P00352 4/20 0.39
APEX1 P27695 1/20 0.39
KDM4E B2RXH2 4/20 0.39
HPGD P15428 2/20 0.39
THRB P10828 1/20 0.39
MAPT P10636 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 1/20 0.38
POLB P06746 2/20 0.38
PSMD14 O00487 1/20 0.37
RECQL P46063 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
AKR1C2 P52895 1/20 0.36
ALOX5 P09917 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316385 0.84 GAA (0.49) GAAALDH1A1KDM4EHPGDMAPT
SCHEMBL6316304 0.79 GAA (0.39) GAATBXAS1ALDH1A1KDM4EMAPT
SCHEMBL11013370 0.78 GAA (0.43) GAATBXAS1PTPN5ALDH1A1APEX1
SCHEMBL6323296 0.76 GAA (0.43) GAATBXAS1PTPN5ALDH1A1APEX1
SCHEMBL6316703 0.74 ALDH1A1 (0.48) TBXAS1ALDH1A1KDM4EHPGDMAPT
SCHEMBL6318596 0.74 ALOX5 (0.41) GAAALDH1A1KDM4EHPGDMAPT
SCHEMBL6317347 0.73 KMT2A (0.47) ALDH1A1KDM4EHPGDMAPTKMT2A
SCHEMBL18932673 0.72 ALDH1A1 (0.59) GAAALDH1A1KDM4EHPGDTHRB
SCHEMBL6317186 0.71 LMNA (0.42) GAATBXAS1KDM4EHPGDMAPT
SCHEMBL6315285 0.71 SPHK1 (0.44) GAATBXAS1ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951848-B2 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC., (US) 2005-10-04 US disclosed
US-20050075348-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-04-07 US disclosed
EP-1377549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR Millennium Pharmaceuticals, Inc. (US) 2004-01-07 EP disclosed
US-20030064991-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2003-04-03 US disclosed
WO-2002072549-A1 FUNCTIONALIZED HETEROCYCLES AS MODULATORS OF CHEMOKINE RECEPTOR FUNCTION AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS, INC. (US) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030064991-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor ACKR3, CCR5, CXCR4 GAA 3980/4885TBXAS1 549/4885PTPN5 1503/4885
US-20050075348-A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor ACKR3, CCR5, CXCR4 GAA 3668/4885TBXAS1 592/4885PTPN5 1418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.